Intellia’s in vivo CRISPR therapy first to succeed in Phase 3

An ex­per­i­men­tal treat­ment that us­es CRISPR to ed­it genes di­rect­ly in­side the body has just suc­ceed­ed in a Phase 3 tri­al — a first for the …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.